Saturday, October 10, 2026 SourcesAbout🌓
🇺🇸 US ▾
BREAKING
› Dominion still has pending lawsuits against election deniers such as Rudy Giuliani and Sidney Powell› Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials› Podcast: One country musician is calling for other artists to oppose assault rifles› Bidets save you money and reduce waste — we tested the best options out there› 50+ products to make your life easier and our planet cleaner› Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love› A head-to-toe guide of how men should dress this spring, and where they should shop› 42 of the most useful travel products you can buy on Amazon› The 7 best high-yield savings accounts of April 2023› Taxes are due tomorrow. Here's how to file for an extension› Dominion still has pending lawsuits against election deniers such as Rudy Giuliani and Sidney Powell› Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials› Podcast: One country musician is calling for other artists to oppose assault rifles› Bidets save you money and reduce waste — we tested the best options out there› 50+ products to make your life easier and our planet cleaner› Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love› A head-to-toe guide of how men should dress this spring, and where they should shop› 42 of the most useful travel products you can buy on Amazon› The 7 best high-yield savings accounts of April 2023› Taxes are due tomorrow. Here's how to file for an extension
Business

Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion

CNBC ·

Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.

Read the full article on CNBC ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.

More from CNBC

See all ›

More in Business

See all ›